GlassScriptPhysician profile
Joseph Cline
NPI 1801356720
$1,260.13
in general payments reported to CMS, 2019-2025
13 companies · $1,260 in 2025
The $1,260 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $352.81 | 2025 | Barrigel |
| Olympus America INC. | $160.20 | 2025 | Itind System |
| Coloplast Corp | $153.70 | 2025 | |
| Janssen Biotech, INC. | $139.65 | 2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $110.25 | 2025 | Provenge |
| E.R. Squibb & Sons, L.L.C. | $102.00 | 2025 | Zeposia |
| Ferring Pharmaceuticals INC. | $83.59 | 2025 | Adstiladrin |
| Astellas Pharma US INC | $37.90 | 2025 | Xtandi |
| Endo USA, INC. | $29.69 | 2025 | Xiaflex |
| Urogen Pharma, INC. | $29.27 | 2025 | |
| Boston Scientific Corporation | $24.17 | 2025 | Ams 700 |
| Merck Sharp & Dohme LLC | $20.26 | 2025 | Keytruda |
| Abbvie INC. | $16.64 | 2025 | Lupron Depot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.